ETNB
Price
$10.41
Change
+$0.79 (+8.21%)
Updated
Jun 13 closing price
Capitalization
1.52B
54 days until earnings call
LENZ
Price
$29.00
Change
-$0.58 (-1.96%)
Updated
Jun 13 closing price
Capitalization
816.24M
Interact to see
Advertisement

ETNB vs LENZ

Header iconETNB vs LENZ Comparison
Open Charts ETNB vs LENZBanner chart's image
89bio
Price$10.41
Change+$0.79 (+8.21%)
Volume$3.93M
Capitalization1.52B
LENZ Therapeutics
Price$29.00
Change-$0.58 (-1.96%)
Volume$156.51K
Capitalization816.24M
ETNB vs LENZ Comparison Chart
Loading...
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETNB vs. LENZ commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETNB is a Hold and LENZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (ETNB: $10.41 vs. LENZ: $29.00)
Brand notoriety: ETNB and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETNB: 200% vs. LENZ: 62%
Market capitalization -- ETNB: $1.52B vs. LENZ: $816.24M
ETNB [@Biotechnology] is valued at $1.52B. LENZ’s [@Biotechnology] market capitalization is $816.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETNB’s FA Score shows that 0 FA rating(s) are green whileLENZ’s FA Score has 0 green FA rating(s).

  • ETNB’s FA Score: 0 green, 5 red.
  • LENZ’s FA Score: 0 green, 5 red.
According to our system of comparison, both ETNB and LENZ are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETNB’s TA Score shows that 3 TA indicator(s) are bullish while LENZ’s TA Score has 3 bullish TA indicator(s).

  • ETNB’s TA Score: 3 bullish, 5 bearish.
  • LENZ’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ETNB and LENZ are a bad buy in the short-term.

Price Growth

ETNB (@Biotechnology) experienced а +1.56% price change this week, while LENZ (@Biotechnology) price change was -9.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

ETNB is expected to report earnings on Aug 07, 2025.

LENZ is expected to report earnings on Mar 19, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ETNB($1.52B) has a higher market cap than LENZ($816M). ETNB YTD gains are higher at: 33.120 vs. LENZ (0.450). LENZ has higher annual earnings (EBITDA): -59.36M vs. ETNB (-380.21M). ETNB has more cash in the bank: 639M vs. LENZ (194M). LENZ has less debt than ETNB: LENZ (1.18M) vs ETNB (37.6M). ETNB (0) and LENZ (0) have equivalent revenues.
ETNBLENZETNB / LENZ
Capitalization1.52B816M186%
EBITDA-380.21M-59.36M640%
Gain YTD33.1200.4507,355%
P/E RatioN/A43.94-
Revenue00-
Total Cash639M194M329%
Total Debt37.6M1.18M3,181%
TECHNICAL ANALYSIS
Technical Analysis
ETNBLENZ
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 6 days ago
86%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 1 day ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ETNB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LENZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PROVX19.27N/A
N/A
Provident Trust Strategy
EMSQX19.09N/A
N/A
Shelton Emerging Markets Institutiona
AMOMX22.63-0.24
-1.05%
AQR Large Cap Momentum Style I
SLASX39.99-0.50
-1.23%
Selected American Shares S
JGINX72.64-0.98
-1.33%
Janus Henderson Growth And Income I

ETNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETNB has been loosely correlated with AKRO. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ETNB jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETNB
1D Price
Change %
ETNB100%
+8.21%
AKRO - ETNB
60%
Loosely correlated
+3.85%
IDYA - ETNB
54%
Loosely correlated
-0.45%
CRNX - ETNB
52%
Loosely correlated
-1.24%
SNDX - ETNB
51%
Loosely correlated
-3.94%
DNLI - ETNB
51%
Loosely correlated
-2.51%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BEAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
-1.96%
BEAM - LENZ
46%
Loosely correlated
-2.18%
ATXS - LENZ
45%
Loosely correlated
+2.14%
ZYME - LENZ
45%
Loosely correlated
-3.28%
XNCR - LENZ
44%
Loosely correlated
-2.55%
CRNX - LENZ
44%
Loosely correlated
-1.24%
More